Blood-Group Serology and Compatibility Testing
Blood-group serology is the branch of laboratory medicine that identifies the antigens carried on red blood cells and the antibodies present in plasma, and uses that information to select blood components that a recipient can receive safely. It underpins safe transfusion by predicting and preventing antigen-antibody reactions between donor and recipient blood.
Definition
Blood-group serology and compatibility testing comprise the laboratory determination of red-cell antigens and plasma antibodies and the matching of donor units to recipients so that transfused red cells survive normally and do not provoke a haemolytic reaction.
Scope
This area orients the reader to the immunohematology that supports transfusion: the major and minor blood-group systems, the detection of clinically significant antibodies, the antiglobulin (Coombs) techniques that reveal red-cell coating, and the pre-transfusion workflow of grouping, screening, and crossmatching. It is a reference overview of how compatibility is established in the laboratory, not a transfusion-practice protocol.
Sub-topics
Core questions
- Which blood-group antigens does an individual carry, and which antibodies are present in their plasma?
- How are clinically significant red-cell antibodies detected and identified before transfusion?
- How does the antiglobulin (Coombs) reaction reveal antibody coating of red cells?
- How are donor units selected and confirmed compatible with a recipient?
Key concepts
- Red-cell antigens and the blood-group systems
- Naturally occurring versus immune antibodies
- ABO and Rh as the clinically dominant systems
- Antibody screening and identification
- Direct and indirect antiglobulin (Coombs) testing
- Type-and-screen and crossmatch workflow
- Clinically significant versus insignificant antibodies
Mechanisms
Red cells display inherited carbohydrate and protein antigens; exposure to non-self antigens through transfusion or pregnancy, or naturally occurring isoagglutinins in the ABO system, can generate antibodies. When antibody meets the corresponding antigen, agglutination or complement-mediated lysis can follow. Serological testing exploits these reactions in vitro: forward and reverse grouping establish ABO type, antibody screens against reagent red cells detect unexpected antibodies, and the antiglobulin reagent bridges IgG-coated cells to make otherwise invisible sensitisation visible as agglutination. Compatibility testing combines these results so that selected units lack the antigens against which the recipient has antibodies.
Clinical relevance
The disciplines summarised here describe how transfusion services prevent haemolytic transfusion reactions and how laboratory evidence is generated; they explain principles rather than prescribe transfusion decisions, which rest with treating clinicians and local protocols. Understanding the area supports critical reading of transfusion and immunohematology literature.
Evidence & guidelines
Practice in this area is consolidated in reference texts such as Daniels' Human Blood Groups, the AABB Technical Manual, and Mollison's Blood Transfusion in Clinical Medicine, alongside narrative reviews of transfusion practice and its adverse effects. These sources describe consensus laboratory methods rather than experimental comparisons.
History
The field began with Karl Landsteiner's discovery of the ABO groups at the turn of the twentieth century, followed by the identification of the Rh system by Landsteiner and Wiener and the elucidation of Rh haemolytic disease by Levine. The introduction of the antiglobulin test by Coombs, Mourant, and Race in the 1940s made it possible to detect incomplete (IgG) antibodies, and the subsequent decades saw the cataloguing of dozens of additional blood-group systems and the standardisation of pre-transfusion testing.
Key figures
- Karl Landsteiner
- Philip Levine
- Robert Coombs
- Geoff Daniels
Related topics
Seminal works
- daniels-2013
- mollison-2014
- panch-2019
Frequently asked questions
- What is the difference between blood typing and crossmatching?
- Typing determines a person's ABO and Rh antigens and screens their plasma for antibodies; crossmatching is the final check that a specific donor unit is compatible with that recipient's plasma before issue.
- Why is the ABO system the most important in transfusion?
- Most people have naturally occurring antibodies against the ABO antigens they lack, so ABO-incompatible red cells can trigger immediate, complement-mediated intravascular haemolysis, making ABO matching the foundation of safe transfusion.